Full Paper
a Dr. Kernchen Propol Digital Automatic polarimeter with 1 cm cu-
vettes at a wavelength of 589 nm. Free-living adult male specimens
of the target amphibian species were caught in the field at night
in 2013 and 2014, during the respective breeding season; males
emitting advertisement calls and thus being in the breeding condi-
tion (30 mL) was added. The aqueous phase was extracted with
ethyl acetate (3 × 75 mL). The organic phase was washed with brine
(50 mL) and dried with MgSO4. After removal of the solvents, col-
umn chromatography (pentane/Et2O, 20:1) yielded the desired
methyl ester 10 in 73 % yield over three steps (819 mg, 3.25 mmol).
tion were specifically selected. The frogs were sedated by the appli- The (R)-enantiomer was obtained using (R)-dihydrofarnesol in 65 %
cation of a small quantity of benzocaine, which is absorbed through yield over 3 steps under identical conditions. TLC (pentane/Et2O,
the frog's skin, and euthanized by an overdose of the same sub- 20:1): Rf 0.43. H NMR (300 MHz, CDCl3): δ = 0.94 (d, JH,H = 6.6 Hz,
stance in the field laboratory. Tissue from the vocal sac (hyperoliids) 3 H, CH3), 1.26–1.42 (m, 2 H, CH2), 1.60 (s, 6 H, 2 × CH3), 1.68 (d,
or the femoral gland (mantellids) was removed with sterilized scis- 3JH,H = 1.1 Hz, 3 H, CH3), 1.90–2.07 (m, 7 H, 3 × CH2, CH), 2.08–2.36
1
3
sors and tweezers, and immediately fixed in dichloromethane for
chemical analysis. Samples were stored in 1 mL GC vials sealed
with Teflon-lined caps to prevent modification or evaporation of
compounds.
(m, 2 H, CH2), 3.67 (s, 3 H, CH3), 5.07–5.13 (m, 2 H, 2 × CH) ppm. 13
C
NMR (75 MHz, CDCl3): δ = 15.9, 17.7, 19.6, 25.3, 25.7, 26.7, 30.0, 36.7,
39.7, 41.6, 51.3, 124.1, 124.3, 131.3, 135.7, 179.7 ppm. EI-MS (70 eV):
m/z (%) 252 (2) [M]+, 237 (2), 209 (55), 177 (18), 163 (3), 151 (6), 135
(7), 123 (41), 109 (100), 95 (26), 85 (13), 81 (24), 73 (8), 69 (99), 59
(S,E)-2,3-Dihydrofarnesol (8): The catalyst [Ru{(R)-tol-binap}](OAc)2
(324 mg, 0.36 mmol, 0.02 equiv.) was added to a solution of (E,E)-
farnesol (7, 4.00 g, 17.99 mmol, 1.0 equiv.) in degassed MeOH
(35 mL) in a 40 mL cylindrical glass vial equipped with a magnetic
stirrer bar that was transferred into a Teflon-lined high-pressure
hydrogenation autoclave. The autoclave was purged with nitrogen,
filled with hydrogen gas (35 bar), and the solution was stirred for
5 h at room temperature. The crude reaction mixture was then
stirred for 10 min with added silica (3.24 g, 1000 wt.-% of catalyst)
and then filtered. The filtrate was stirred again with activated char-
coal (16 g, 400 wt.-% of starting material) for 15 min and filtered
through a short silica plug. (S,E)-2,3-dihydrofarnesol (8) was ob-
tained as a light yellow liquid ready to use without further purifica-
tion in the next step (yield: 3.89 g, 17.34 mmol, 96 %). (R,E)-2,3-
dihydrofarnesol was obtained in 89 % yield by using [Ru{(S)-tol-
binap}](OAc)2 as the catalyst.[11] 1H NMR (400 MHz, CDCl3): δ = 0.91
(15), 55 (18), 41 (51). IR (GC-IR): ν = 2961 (s), 2921 (s), 2853 (s), 2729
˜
(w), 1738 (s), 1702 (w), 1672 (w), 1437 (s), 1377 (s), 1289 (s), 1261
(m), 1197 (s), 1153 (s), 1108 (m), 1009 (m), 838 (m) cm–1. (S)-10:
[α]2D1.6 = –4.6 (c = 1.01 in CH2Cl2). (R)-10: [α]2D5.0 = +4.1 (c = 0.78 in
CH2Cl2).
Methyl (3S,6E,10E)-12-Hydroxy-2,3-dihydrofarnesenoate (11): A
solution of SeO2 (44 mg, 0.396 mmol, 0.2 equiv.) and tBuOOH
(3.96 mmol, 2.0 equiv., 0.72 mL of a 5.5
M solution in nonane) in
CH2Cl2 (10 mL) was stirred for 30 min at room temperature.[13] Ester
10 (0.5 g, 1.98 mmol, 1 equiv.) was added at 0 °C. After stirring for
5 h at room temperature Na2SO3 solution (10 mL) was added, and
the aqueous phase was extracted three times with ethyl acetate
(3 × 15 mL). The combined organic phases were washed with brine
(10 mL), dried with MgSO4, and the solvents were removed. Column
chromatography (pentane/ethyl acetate, 2:1) yielded 25 % of the
desired product (133 mg, 0.495 mmol) 11 and 13 % of its regioiso-
3
[d, J(H,H) = 6.6 Hz, 3 H], 1.14–1.43 (m, 5 H), 1.60 (s, 6 H), 1.68 (s, 3
H, CH3), 1.96–2.09 (m, 6 H), 3.63–3.74 (m, 2 H), 5.07–5.13 (m, 2 H)
mer 12 (69 mg, 0.257 mmol). The (R)-enantiomer of 11 was ob-
1
ppm. 13C NMR (100 MHz, CDCl3): δ = 15.9, 17.7, 19.5, 25.4, 25.7, tained similarly in 22 % yield. TLC (pentane/EtOAc, 2:1): Rf 0.54. H
3
26.7, 29.2, 37.2, 39.7, 39.9, 61.2, 124.3, 124.6, 131.3, 134.9 ppm. EI- NMR (400 MHz, CDCl3): δ = 0.94 (d, JH,H = 6.6 Hz, 3 H, CH3), 1.18–
MS (70 eV): m/z (%) 224 (1) [M]+, 209 (1), 181 (33), 163 (19), 149 (2),
1.40 (m, 2 H, CH2), 1.60 (s, 3 H, CH3), 1.66 (s, 3 H, CH3), 1.94–2.34
(m, 9 H, 4 × CH2, CH), 3.67 (s, 3 H, CH3), 3.98 (s, 2 H, CH2), 5.08–5.12
(m, 1 H, CH), 5.36–5.40 (m, 1 H, CH) ppm. 13C NMR (100 MHz, CDCl3):
δ = 13.6, 15.9, 19.5, 25.2, 25.9, 29.8, 36.6, 39.2, 41.5, 51.3, 68.7, 124.4,
125.6, 134.7, 134.8, 173.8 ppm. EI-MS (70 eV): m/z (%) 250 (14) [M
– H2O]+, 235 (2), 219 (1), 207 (3), 199 (51), 194 (4), 181 (3), 175 (6),
167 (100), 161 (4), 149 (16), 139 (28), 121 (47), 107 (36), 93 (30), 81
137 (5), 123 (54), 109 (21), 95 (47), 81 (71), 69 (100), 55 (26), 41 (56).
IR (GC/IR): ν [cm–1] 3274 (br.s), 2965 (s), 2926 (s), 2863 (s), 2853 (s),
˜
1676 (w), 1451 (s), 1377 (s), 1107 (m), 1060 (s), 1013 (m). (S)-8:
[α]2D1.6 = +24.2 (c = 0.96 in CH2Cl2). (R)-8: [α]2D5.0 = –26.4 (c = 1.10 in
CH2Cl2).
Methyl (S,E)-2,3-Dihydrofarnesenoate (10): A solution of pyrid-
ine·SO3 (2.12 g, 13.32 mmol, 3.0 equiv.) in DMSO (50 mL) was stirred
for 15 min at room temperature. This mixture was added to a solu-
tion of (S)-8 (1.00 g, 4.45 mmol, 1.0 equiv.) and NEt3 (3.08 mL,
44.50 mmol, 10.0 equiv.) in CH2Cl2 (150 mL) at 0 °C. After stirring
for 3 h at room temperature water was added (100 mL). The aque-
ous phase was extracted three times with CH2Cl2 (3 × 50 mL), and
the combined organic phases were dried with MgSO4. The crude
aldehyde 9 was used directly in the next reaction step after removal
of the solvents.[12]
(22), 77 (8), 69 (43), 65 (4), 59 (17), 55 (29), 41 (36). IR (GC-IR): ν =
˜
3279 (br.s), 2956 (s), 2918 (s), 2853 (s), 1736 (s), 1672 (w), 1438 (s),
1377 (s), 1290 (s), 1198 (s), 1154 (s), 1105 (m), 1072 (s), 1011 (s), 958
(w), 879 (w), 844 (m) cm–1. S-11: [α]D21.6 = –2.4 (c = 0.98 in CH2Cl2).
R-11: [α]2D5.0 = +3.4 (c = 1.80 in CH2Cl2).
(3S,6E,10E)-3,7,11-Dodec-6,10-dien-12-olide, Frogolide (14):
Lithium hydroxide (97 mg, 4.06 mmol, 20 equiv.) was added to the
ester 11 (55 mg, 0.203 mmol, 1 equiv.) dissolved in a mixture of
THF (2 mL), methanol (2 mL), and water (1 mL).[15] The resulting
mixture was heated to reflux at 80 °C for 14 h. After addition of sat.
Aldehyde 9 (989 mg, 4.45 mmol, 1.0 equiv.) was added to a solution
of NaH2PO4 (5.34 g, 44.5 mmol, 10.0 equiv.), 2-methyl-2-butene
(20 mL), tert-butanol (15 mL) in THF (50 mL) and water (50 mL).
Sodium chlorite (2.01 g, 22.25 mmol, 5.0 equiv.) was added partially
in three equal portions every 45 min. After addition of the last
portion, the mixture was stirred for an additional hour. Water was
added (50 mL), and the aqueous phase was extracted three times
with ethyl acetate (3 × 75 mL). The organic phase was washed with
brine (50 mL), dried with MgSO4, and the solvents were removed.
The residue was taken up in DMF (15 mL) and methyl iodide
NH4Cl solution (3 mL), the mixture was acidified using 2
M HCl (ca.
1 mL), and the aqueous phase was extracted three times with ethyl
acetate (3 × 5 mL). After removal of the solvent, the resulting crude
acid 13 was used directly in the next step without further purifica-
tion.
Triethylamine (144 mg, 200 μL, 1.42 mmol, 7 equiv.) and bis(2-oxo-
3-oxazolidinyl)phosphinic chloride (BOP-Cl, 155 mg, 0.609 mmol,
3 equiv.) were added to a solution of the hydroxyacid 13 (52 mg,
0.203 mmol, 1 equiv.) in CH2Cl2 (5 mL). The resulting mixture was
(1.264 g, 8.9 mmol, 2.0 equiv.) and K2CO3 (0.922 g, 6.68 mmol, stirred for 6 h at room temperature, and sat. NH4Cl solution (5 mL)
1.5 equiv.) were added. After stirring for 30 min, sat. NaHCO3 solu-
was added. The aqueous phase was extracted three times with
Eur. J. Org. Chem. 0000, 0–0
5 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim